INTERCHANGEABILITY OF MYOCARDIAL CYTOPROTECTORS IN PATIENTS WITH ISCHEMIC HEART DISEASE. DIFFICULT QUESTIONS –SIMPLE SOLUTIONS

Autor:	Zh. M. Sizova
Jazyk:	English<br />Russian
Rok vydání:	2015
Předmět:	ишемическая болезнь сердца хроническая сердечная недостаточность стенокардия прекондиционирование цитопротекция триметазидин оригинальный препарат дженерик фармакотерапия Therapeutics. Pharmacology RM1-950 Diseases of the circulatory (Cardiovascular) system RC666-701
Zdroj:	Рациональная фармакотерапия в кардиологии, Vol 9, Iss 2, Pp 183-187 (2015)
Druh dokumentu:	article
ISSN:	1819-6446 2225-3653
DOI:	10.1234/1819-6446-2013-2-183-187
Popis:	Indications for myocardial cytoprotector, trimetazidine, in patients with ischemic heart disease are analyzed and justified according to evidence based medicine. Results of a multicenter randomized comparative KARDIOKANON study are discussed in terms of efficacy and tolerability of two variants of the complex 12-week treatment in patients with angina II-III functional class, based on the original and generic drugs. The study showed clinical equivalence of the generic DeprenormR (Canonpharma Production) to the original trimetazidine.
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/bb681936a7a04ff4893e2e1ff2570f2b Zobrazit plný text záznamu View record in DOAJ